Skip to content
Screener

Pre-Tax Income at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$554M-21.2%
Stryker logo
StrykerSYK
$1.56B+53.9%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$9.54M-58.9%
MiMedx Group logo
MiMedx GroupMDXG
-$17.78M-237%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$2.97M+136%
AbbVie logo
AbbVieABBV
$4.28B+175%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.33B+38.0%
Enterprise value$3.08B+16.2%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income4,2674,7108,3729,130
Interest expense(22,994)(21,042)(45,459)(39,857)
Other income (expense), net4,186(1,946)8,665(2,090)
Income (loss) before income taxes4,744(530,952)2,333(560,988)
Provision (benefit) for income taxes262(46,879)2,467(51,622)
Net income (loss)$4,482$(484,073)$(134)$(509,366)
Net income (loss) per share
Basic$0.06$(6.31)$(6.65)

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's pre-tax income?
Integra LifeSciences (IART) reported pre-tax income of $4.74M in Q2 2026.
How has Integra LifeSciences's pre-tax income changed year-over-year?
Integra LifeSciences's pre-tax income increased by 100.9% year-over-year, from -$530.95M to $4.74M.
What is the long-term trend for Integra LifeSciences's pre-tax income?
Over 3 years (2021 to 2025), Integra LifeSciences's pre-tax income has grown at a 38.3% compound annual growth rate (CAGR), from $214.68M to -$567.81M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about Integra LifeSciences's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude